Pfizer Stays On Message On Celebrex Safety Data, DoJ Investigation
Executive Summary
Pfizer has not identified a new cardiovascular safety signal in three Celebrex controlled cancer prevention studies that were halted, the company said Jan. 19
You may also be interested in...
Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says
Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19
Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says
Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19
Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules
An FDA "untitled" letter to Pfizer on Celebrex and Bextra is the agency's second recent objection to the company's interpretation of the boundaries of "reminder" ads